UBS Group’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,176
| Closed | -$37K | – | 7430 |
|
|
2019
Q2 | $37K | Sell |
7,176
-5,375
| -43% | -$27.7K | ﹤0.01% | 5312 |
|
|
2019
Q1 | $46K | Sell |
12,551
-6,663
| -35% | -$24.4K | ﹤0.01% | 4809 |
|
|
2018
Q4 | $118K | Buy |
19,214
+7,863
| +69% | +$48.3K | ﹤0.01% | 4531 |
|
|
2018
Q3 | $66K | Sell |
11,351
-661
| -6% | -$3.84K | ﹤0.01% | 5072 |
|
|
2018
Q2 | $51K | Buy |
12,012
+2,961
| +33% | +$12.6K | ﹤0.01% | 5054 |
|
|
2018
Q1 | $40K | Sell |
9,051
-3,758
| -29% | -$16.6K | ﹤0.01% | 5033 |
|
|
2017
Q4 | $68K | Buy |
12,809
+3
| +0% | +$16 | ﹤0.01% | 4674 |
|
|
2017
Q3 | $79K | Buy |
12,806
+1,343
| +12% | +$8.29K | ﹤0.01% | 4606 |
|
|
2017
Q2 | $83K | Buy |
11,463
+1,102
| +11% | +$7.98K | ﹤0.01% | 4402 |
|
|
2017
Q1 | $55K | Buy |
10,361
+3,147
| +44% | +$16.7K | ﹤0.01% | 4563 |
|
|
2016
Q4 | $52K | Sell |
7,214
-1,267
| -15% | -$9.13K | ﹤0.01% | 4893 |
|
|
2016
Q3 | $79K | Buy |
8,481
+4,476
| +112% | +$41.7K | ﹤0.01% | 4292 |
|
|
2016
Q2 | $26K | Buy |
4,005
+573
| +17% | +$3.72K | ﹤0.01% | 5217 |
|
|
2016
Q1 | $19K | Buy |
3,432
+3,081
| +878% | +$17.1K | ﹤0.01% | 5429 |
|
|
2015
Q4 | $2K | Sell |
351
-349
| -50% | -$1.99K | ﹤0.01% | 6631 |
|
|
2015
Q3 | $6K | Hold |
700
| – | – | ﹤0.01% | 6220 |
|
|
2015
Q2 | $11K | Sell |
700
-2,577
| -79% | -$40.5K | ﹤0.01% | 5935 |
|
|
2015
Q1 | $52K | Buy |
3,277
+727
| +29% | +$11.5K | ﹤0.01% | 4629 |
|
|
2014
Q4 | $45K | Buy |
+2,550
| New | +$45K | ﹤0.01% | 4823 |
|